Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It is interesting. Essentially the two are moving to the same price again.
Really wanted those 12's but they were purchased too fast.
And it's currently up not down.
Nice conspiracy theory. 8ks filed with the SEC.
Looks like a random number that just undercut the prior ask. Nothing more.
What is Regen's Twitter account name?
Remember the Koos clarification PR s month ago on Small molecule screening? He was incredulous that the market did not react to the PR from two days earlier and felt the need to explain further. The Market yawned at that PR, too. I really think they are close to a financing agreement that Koos believes will make him rich based on the shares he owns. That only happens if the market reacts strongly to a financing PR and I'm sure Koos wants the baseline SP to be as high as possible. Hence the theory on the divvy shares.
One theory is that RGBPP will issue a stock dividend (1 share RGBP for 20 shares owned of RGBPP) very soon. That will get eyes on the company and the SP up for both symbols. Then the company announces sale/partnership/financing and the SP takes off from a much higher place than it currently sits.
That kind of announcement would deliver a 10 capper. I expect a funding announcement soon.
Agreed
Entertaining day. BMSN action interesting, as goes RGBP BMSN will lag but follow. BMSN at .0001 looks like a buy to me. I believe Objective/CIM will catch a big fish and soon.
Ended at 18 on a good day with decent volume. Your chart is upside down.
With regard to Broker payment their real money comes if there is a transaction.
With regard to dilution, lander said his goal was to create value for shareholders and that dilution was to be reduced and (inferred) eliminated sometime after the first quarter. The SP is also 30 pct higher than last month and hopefully rising.
Because Lander is still leading the scientific and capital programs. He made a commitment at the beginning of the year to eliminate dilution and increase SP. He cares about his reputation and seems to want to succeed. He has what appears to be real value in each program and dramatic value if all of it was part of the bargain. He cannot move forward on much without funding. It's not a lot of money, 4.5 million. He's hired brokers who get paid when a transaction occurs and they've been on board since May. Eli lilly has shown interest in the science.
Deal soon.
Trend moving up. Get on board or be left at the station.
Agreed. It also explains no news on Dcell. A reissue of Dcell IND this Qtr. It also puts out there IND application and expected approval of Hema for treatment of effects from chemo this year. It's a highly useful update and supports the idea of a financial deal and dramatic increase in SP very soon.
Looks like the prospectus that Objective is using to raise cash. It seems like a smart investment for Big Pharma investment. This PR is intended to get more eyes to accelerate the financing process.
Looks like the prospectus that Objective is using to raise cash. It seems like a smart investment for Big Pharma investment. This PR is intended to get more eyes to accelerate the financing process.
Unless news tomorrow.
More importantly the resistance at .1399 was taken out.
I have no idea. How about some folks emailing Lander the question and maybe one of us will get a response.
How do Objective Capital and CIM relate to each other?
Dividend?
Dividend?
I was the cheerleader for Q2 and I was pleased with the science advances and the EL partnership. I believe the Objective Capital hire is the key to unlocking value in the stock and believe that they like to work fast as their compensation is tied to performance. A deal will happen in Q3 and we will see the SP trading in a much higher orbit.
Don't forget this startup is trading with a combined value between the pref and common, of close to 30 million. Had we not been diluted this past year the SP would be 2x or more than it is today. I like the 500 million plus value that Lander projected in a PR a few months ago.
I assume they needed Eli Lily's permission to use their name in a PR. That says something about EL's confidence in the science.
I disagree. I believe the lack of upward movement is the F and F plan shares. We may have another 5 million shares to go before those are exhausted. All of this goes away if their M and A broker is successful. Since they work on a success fee I'm hoping to hear something soon. It's clear to me that the science side of this is moving along ntcely. Looking for the SP to start reflecting that success.
That statement serves to replace their quarterly reports.
The bid looks like a lure hoping a seller will misread and put a sell at the bid.
Filing Chapter 7 takes time.
RGBP coiled. Waiting for M and A news. No one selling or buying.
RGBP coiled. Waiting for M and A news. No one selling or buying.
They don't answer their phone. The best they can come up with is "we're still in business". Pathetic.
Stop the presses there was a trade.
No. ANAS is not in business. Empty shell. Sorry.
Agreed. One day of the right news and we launch. The M & A team, NCATs or Big Pharma needs to be involved but all three are actively working with RGBP now so it's no longer if, but when. Childish repetitious gloomy, nonsense is easy to block with the ignore feature.
It's all about getting a money partner and respected 3rd party validation, i.e. NCATS confirmation of results. It's coming.
I think this is friend and family deep discount selling. I'm a buyer at these prices.
Less than 3,000 shares for about $.90? Wow. Garbage
Fact. 22,000 shares or about $70 traded. Pathetic